Adhera Therapeutics, Inc. License Agreements

25 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Addendum to the License Agreement
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
Addendum to License Agreement Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 dated February 16, 2022
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
License Agreement between Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2022
License Agreement between Adhera Therapeutics, Inc. and Melior Pharmaceuticals II, LLC for MLR-1019
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
PA
2021
License Agreement between Marina Biotech, Inc. and Oncotelic, Inc. for SMARTICLES™ and CRN Technologies
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2017
License Agreement between Marina Biotech, Inc. and Lipomedics, Inc. for SMARTICLES™ Technology
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2017
Amendment No. 2 to License Agreement between Mirna Therapeutics, Inc. and Marina Biotech, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2015
License Agreement Between Novartis Institutes for BioMedical Research, Inc. and Marina Biotech, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
Intellectual Property License Agreement between Marina Biotech, Inc. and Monsanto Company
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
Amendment No. 4 to Research and License Agreement between Debiopharm S.A. and Marina Biotech, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2012
Amendment No. 3 to Research and License Agreement between Debiopharm S.A. and Marina Biotech, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2012
Amendment No. 2 to Research and License Agreement between Debiopharm S.A. and Marina Biotech, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2012
Amendment No. 1 to Research and License Agreement between Debiopharm S.A. and Marina Biotech, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2012
Exclusive License Agreement between Marina Biotech, Inc. and ProNAi Therapeutics, Inc. (March 13, 2012)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
DE
2012
License Agreement between Mirna Therapeutics, Inc. and Marina Biotech, Inc. for Liposomal Delivery Technology
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2012
Research and License Agreement between Debiopharm S.A. and Marina Biotech, Inc. (February 3, 2011)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
WA
2011
Amendment No. 3 to Patent Assignment and License Agreement between Ribotask ApS and MDRNA, Inc. dated June 4, 2010
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2010
First Amendment to Development and License Agreement between Amylin Pharmaceuticals, Inc. and MDRNA, Inc. (January 29, 2009)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2010
License Agreement between Novartis Institutes for BioMedical Research, Inc. and MDRNA, Inc. dated March 20, 2009
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
MI
2009
Non-Exclusive Patent License Agreement between Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd, and MDRNA, Inc. (Effective February 12, 2009)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NJ
2009
First Amendment to Product Development and License Agreement between Nastech Pharmaceutical Company Inc. and Procter & Gamble Pharmaceuticals, Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
2007
Development and License Agreement between Amylin Pharmaceuticals, Inc. and Nastech Pharmaceutical Company Inc. (June 21, 2006)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
CA
2006
Product Development and License Agreement between Nastech Pharmaceutical Company Inc. and Procter & Gamble Pharmaceuticals, Inc. (January 27, 2006)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
NY
2006
License and Supply Agreement between Par Pharmaceutical, Inc. and Nastech Pharmaceutical Company Inc. (October 22, 2004)
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
WA
2004
Exclusive Development, Commercialization and License Agreement between Merck & Co., Inc. and Nastech Pharmaceutical Company Inc.
License Agreements
Adhera Therapeutics, Inc.
Biotechnology
DC
2004